TrialJournal of autoimmunity2008

High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis.

Steven Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.